Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals

Technical Trend Overview and Price Movement

As of 6 August 2026, Chandan Healthcare Ltd’s share price closed at ₹248.25, down from the previous close of ₹255.45. The stock’s 52-week high stands at ₹358.00, while the low is ₹185.40, indicating a wide trading range over the past year. The recent price action reflects a retracement from highs, with the technical trend shifting from mildly bearish to sideways, signalling a potential pause in the downtrend.

The daily moving averages remain mildly bearish, suggesting that short-term momentum is still under pressure. However, weekly indicators such as the MACD and KST have turned mildly bullish, hinting at a possible recovery or consolidation phase. The Bollinger Bands on the weekly chart also show bullish tendencies, indicating that volatility may be increasing with a bias towards upward movement in the near term.

MACD and RSI Signals

The Moving Average Convergence Divergence (MACD) indicator on the weekly timeframe has improved to a mildly bullish stance, reflecting a positive crossover or narrowing gap between the MACD line and the signal line. This suggests that buying momentum is gradually building after a period of weakness. Conversely, the monthly MACD remains inconclusive, indicating that longer-term momentum has yet to confirm a sustained uptrend.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This lack of extreme readings implies that the stock is neither overbought nor oversold, which aligns with the sideways technical trend. Investors should watch for any RSI movement beyond the 70 or below 30 thresholds to identify potential breakout or breakdown scenarios.

Volume and On-Balance Volume (OBV) Analysis

Volume-based indicators provide additional insight into the stock’s momentum. The On-Balance Volume (OBV) is mildly bullish on both weekly and monthly charts, suggesting that accumulation may be occurring despite the recent price decline. This divergence between price and volume can often precede a reversal or stabilisation in price trends, signalling that institutional investors might be gradually increasing their holdings.

Moving Averages and Dow Theory Perspectives

Daily moving averages remain mildly bearish, reflecting short-term selling pressure. This is consistent with the stock’s recent price decline of 2.82% on the day. However, the weekly Dow Theory assessment remains mildly bearish, while the monthly Dow Theory shows no clear trend. This mixed outlook suggests that while short-term momentum is weak, the longer-term trend is yet to be decisively established.

Investors should monitor the stock’s ability to hold key moving average support levels, particularly the 50-day and 200-day averages, to gauge whether the sideways trend will evolve into a bullish phase or resume its downward trajectory.

Relative Performance Versus Sensex

Chandan Healthcare Ltd’s returns have lagged the broader Sensex index over most timeframes. The stock outperformed the Sensex marginally over the past week, with a 2.16% gain compared to the Sensex’s 1.54%. However, over the past month, the stock declined by 1.88% while the Sensex rose 1.46%. Year-to-date, the stock has fallen 23.51%, significantly underperforming the Sensex’s 5.76% loss. Over the last year, the stock’s return was -3.39%, compared to the Sensex’s near-flat performance of -0.11%.

This underperformance highlights the challenges faced by Chandan Healthcare Ltd in regaining investor confidence amid sectoral and company-specific headwinds. The hospital sector itself has seen mixed fortunes, with varying recovery rates across peers.

Mojo Score and Rating Upgrade

MarketsMOJO assigns Chandan Healthcare Ltd a Mojo Score of 51.0, reflecting a Hold rating. This represents an upgrade from the previous Sell grade as of 5 August 2026. The upgrade is driven primarily by the improving technical indicators on the weekly timeframe and the stabilisation of volume trends. However, the micro-cap status and ongoing volatility warrant caution, as the stock remains vulnerable to broader market swings and sector-specific risks.

Outlook and Investor Considerations

Chandan Healthcare Ltd’s technical parameters suggest a stock in transition. The shift from a mildly bearish to a sideways trend, combined with mildly bullish weekly MACD and OBV signals, indicates that the stock may be consolidating before a potential directional move. The neutral RSI readings and mixed Dow Theory signals reinforce the need for investors to watch for confirmation of trend direction.

Given the stock’s recent underperformance relative to the Sensex and the hospital sector, investors should weigh the improving technical signals against fundamental and sectoral factors. The micro-cap nature of the company adds an element of risk and volatility, which may not suit all portfolios.

Summary

In summary, Chandan Healthcare Ltd is exhibiting signs of stabilisation after a period of bearish momentum. The weekly technical indicators such as MACD, KST, and OBV have improved to mildly bullish, while daily moving averages and Dow Theory assessments remain cautious. The sideways trend suggests a consolidation phase, with investors advised to monitor key technical levels and volume patterns for confirmation of a sustained recovery.

Relative to the Sensex, the stock has underperformed over most periods, reflecting sectoral challenges and company-specific factors. The recent upgrade from Sell to Hold by MarketsMOJO underscores the evolving technical landscape but also highlights the need for prudence given the stock’s micro-cap status and volatility.

For investors considering exposure to the hospital sector, Chandan Healthcare Ltd presents a mixed technical picture that warrants close observation. Those seeking momentum plays or more stable options may find better opportunities elsewhere within the sector or across market caps.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today